Energy & Environment
ICT & Digital
Life Sciences & Health
Nutrition & FoodTech
Precision Engineering


The new scale-ups facing the challenge of expansion

9 new companies have obtained the Scale-Up Vaud label at the beginning of the year 2024. These are companies in various innovative fields, all facing the challenge of expansion. Bilan magazine met with some members of this community.


Scale-Up Vaud highlighted in 24 heures

The Scale-Up Vaud community boasts numerous exceptional companies. Innovaud accompanies them during this crucial transition. The Vaud newspaper 24 heures has gathered testimonies from two CEOs as well as from Charlotte Ducrot, co-manager of the Scale-Up Vaud program.


ONWARD Medical Successfully Raises €20 Million

The medical scale up creating innovative spinal cord stimulation therapies to restore movement, function, and
independence in people with spinal cord injury (SCI) and movement disorders, announces that it successfully raised an amount of €20 million.


45 companies have been awarded the Scale-Up Vaud 2024 label

Innovaud announces the list of 45 scale-ups, including 9 new companies, which have been awarded the Scale-Up Vaud 2024 label. All these Vaud-based companies have created more than 6700 jobs in Switzerland and around the world. Presentation of statistics as well as the new scale-ups.


TotalEnergies acquires Predictive Layer

To contribute to the acceleration of its development in the electricity business, TotalEnergies acquires Predictive Layer, for its machine learning and artificial intelligence solutions.


CYSEC wins a European Space Agency award

CYSEC wins the ESA Push 2023 in the Satellite as a Service Category .


Daphne Technology launches U.S. subsidiary in Houston, Texas, to lead the charge in reducing methane

Committed to combating methane emissions, this move aligns with tightening US regulations, marking a pivotal step in their mission to make a tangible impact on reducing pollution.


MedAlliance Acquired by Cordis for up to USD 1.135 Billion

MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029, for a total consideration of up to $1.135 Billion.


Lunaphore to get acquired by Bio-Techne

Lunaphore Technologies SA, a Swiss life sciences scale-up developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3.